Name: UPC Balance Sheet - Universe Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

UPC - Universe Pharmaceuticals Inc.

USD | NASDAQ | Healthcare

UPC Balance Sheet - Universe Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Cash And Short Term Investments
Cash And Equivalents	-	-	-	-	8.1	10.1	3.2	6.2
Restricted Cash	-	-	-	-	-	-	-	-
Short Term Investments	-	-	13.2	13.1	13.7	-	-	-
Cash And Short Term Investments	-	-	-	-	21.8	10.1	3.2	6.2
Receivables
Accounts Receivable	13,008.1	12,905.8	11.0	15.2	15.6	10.9	-	-
Current Assets
Inventory	2,193.2	1,737.1	3.3	2.2	2.5	1.9	-	-
Prepaid Expenses	39.9	852.4	0.0	1.7	-	-
Non-Current Assets
Property, Plant & Equipment Gross	10,487.3	10,232.8	9.8	10.0	10.5	9.5	-	-
Accumulated Depreciation	6,903.8	6,664.8	6.1	5.7
Current Liabilities
Accounts Payable	1,669.8	4,914.8	4.6	3.1	5.3	2.7	-	-
Short Term Debt	2,107.0	5,856.7	5.5	3.9	4.3	2.6
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	-	-	-
Common Equity
Common Stock	6,337.6	482.4	0.1	0.1	0.1	0.1	-	-
Additional Paid In Capital	-	-	-	29.3	29.3
Supplementary Data
Total Debt	2,107.0	5,856.7	5.5	3.9	4.3	2.6	-	-
Net debt	-	-	-	-	(17.5)	(7.4)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q4 FY 25	Q4 FY 24	Q2 FY 24	Q4 FY 23	Q2 FY 23	Q4 FY 22	Q2 FY 22	Q4 FY 21	Q4 FY 20	Q4 FY 19	Q4 FY 18
Cash And Short Term Investments
Cash And Equivalents	-	-	-	-	-	-	-	-	10.1	3.2	6.2
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	2.5	13.2	-	13.1	-	13.7	-	-	-
Cash And Short Term Investments	-	-	-	-	-	-	-	-	10.1	3.2	6.2
Receivables
Accounts Receivable	13,008.1	12,905.8	14.4	10.7	-	15.2	-	-	10.9	-	-
Current Assets
Inventory	2,193.2	1,737.1	3.4	3.3	-	2.2	-	-	1.9	-	-
Prepaid Expenses	39.9	852.4	0.5
Non-Current Assets
Property, Plant & Equipment Gross	10,487.3	10,232.8	9.9	9.8	-	10.0	-	-	9.5	-	-
Accumulated Depreciation	6,903.8
Current Liabilities
Accounts Payable	1,669.8	4,914.8	7.8	4.6	-	3.1	-	-	2.7	-	-
Short Term Debt	2,107.0	5,856.7	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-
Common Equity
Common Stock	6,337.6	482.4	0.1	0.1	-	0.1	-	-	0.1	-	-
Additional Paid In Capital	-	-	-
Supplementary Data
Total Debt	2,107.0	5,856.7	-	-	1.1	3.9	-	-	2.6	-	-
Net debt	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)